<DOC>
	<DOCNO>NCT00450840</DOCNO>
	<brief_summary>The beneficial effect statins prevent cardiovascular event patient risk well establish . Recent trial demonstrate statin exert number vascular action independent lipid lower . Short-term simvastatin therapy recently report reduce mortality 2 different animal model sepsis . Pleiner coworkers could demonstrate potent vasoprotective property simvastatin Escherichia coli endotoxin induce endotoxemia healthy volunteer . In population-based cohort analysis demonstrate administration statin associate reduce risk subsequent sepsis . Thus , simvastatin treatment may offer new therapeutic strategy clinical condition associate inflammation like severe sepsis septic shock . The aim present study test hypothesis short term treatment simvastatin may mitigate detrimental vascular effect acute inflammation patient admit intensive care unit require treatment septic shock .</brief_summary>
	<brief_title>Simvastatin Patients With Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Age &gt; 18 year Septic Shock le 48 hour Pregnancy Unable receive enteral medication Expected survival le 72 hour Treatment previous 3 week simvastatin HMGCoA reductase inhibitor History hypersensitivity trial drug drug similar chemical structure History know suspect porphyria High risk rhabdomyolysis ( multiple trauma , crush injury , extensive burn , baseline creatinine kinase ( CK ) â‰¥tentimes upper limit normal Hemorrhagic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>septic shock</keyword>
	<keyword>simvastatin</keyword>
</DOC>